Article
Restructuring of the Immune Contexture Improves Checkpoint Blockade Efficacy in Murine Lung Cancer
2020-10-10
Abstract excerpt
<h4>ABSTRACT</h4> Therapeutic options for non-small cell lung cancer (NSCLC) treatment have changed dramatically in recent years with the advent of novel immunotherapeutic approaches. Among these, immune checkpoint blockade (ICB), using monoclonal antibodies, has shown tremendous promise in a small proportion of patients. In order to better predict patients that will respond to ICB treatment, biomarkers such as t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eec633f9-a0b6-5a88-b26c-df39988a8362
- DOI
- 10.1101/2020.10.09.332387
